BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home » Topics » Disease categories and therapies » Nephrology

Nephrology
Nephrology RSS Feed RSS

Phenylpiperazine derivatives synthesized at SCRAS claimed for BPH, portal hypertension, cirrhosis

Nov. 8, 2001

Icos acquires rights to resiniferatoxin for urological disorders

Nov. 8, 2001

New potassium channel openers and uses thereof reported by Abbott team

Oct. 31, 2001

Dual M3 and 5-HT4 antagonists claimed in recent patent by Sanofi-Synthelabo

Oct. 29, 2001

Compound for SIADH designated an orphan drug in Japan

Oct. 25, 2001

Long-term tamsulosin has sustained efficacy, safety in LUTS/BPH

Oct. 23, 2001

U.S. phase III efficacy and safety data for Foznol discussed at World Congress of Nephrology

Oct. 19, 2001

Fujisawa identifies new aminoalcohol beta3-adrenoceptor agonists

Oct. 18, 2001

GSK seeks Swedish approval of dutasteride for treatment of BPH

Oct. 18, 2001

FDA issues approvable letter for UroXatral

Oct. 15, 2001
Previous 1 2 … 258 259 260 261 262 263 264 265 266 … 336 337 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 9, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • Cross section illustration of HIV virus parts

    Anticancer drug exerts potent HIV antiviral effects

    BioWorld Science
    A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing